4.3.2021 15:59:15 CET | Aqua Bio Technology ASA | Non-regulatory press releases

As announced in the stock exchange notice 11 June 2020 -
https://newsweb.oslobors.no/message/507611, Aqua Bio Technology (ABT) has
entered into a strategic partnership with the Canadian company DCP Dermoscience
- https://www.dcpdermoscience.com/en/ (DCP). The DCP agreement gave ABT
exclusive rights to two new skin care series for development of its own brands
and "private label" for ABT's customers. The first two skin care series
following from the DCP agreement will be named "Seidr" and "Seidr Clinique". The
name "Seidr" comes from Norse mythology and refers to supernatural abilities and
powers practiced by strong women. The new brand "Seidr" is developed in close
cooperation with the media bureau Glitch - https://www.glitchstudios.co/ 
Studios. Both "Seidr" and "Seidr Clinique", like ABT's existing products, will
contain high levels of active ingredients.

As announced on 10 September 2020 - https://newsweb.oslobors.no/message/513214,
ABT has also acquired all rights to the skin care series Moana Skincare. As part
of a further commercial development of Moana Skincare, the company will launch
these products under a new sister brand to adapt the products for distribution
to new/other markets than where Moana is sold today. Moana Skincare will
continue to exist, be further developed, and be available to existing and new
customers. The new brand, developed in close collaboration with the media bureau

Atyp - https://atyp.no/, will be launched under the brand "Be Natural".

For "Seidr", "Seidr Clinique" and "Be Natural", ABT Korean Yonwoo Co Ltd -
http://www.yonwoo.kr/en/. (Yonwoo) will be used as a packaging supplier. Yonwoo
was established in 1983 as a manufacturer specializing in packaging materials
for cosmetic and personal care products. Yonwoo is today a leading supplier in
packaging for cosmetics globally.

As mentioned in the stock exchange notice in February 8 2021 -
https://newsweb.oslobors.no/message/524073, Hydrafacial, in collaboration with
Restorsea, has launched its new product Restorsea Lip Fix Kit -
https://hydrafacial.com/brand/restorsea/ based on ABT's hatching fluid
ingredient (Aquabeautine XL). Further, Nasdaq-listed LifeMD (formerly Conversion
Labs) announced in a stock exchange notice in February 22 2021 -
https://ir.lifemd.com/press-release-details.php#/?newsId=2179228 that they are
ready to launch their new product NavaMD which is based on ABT's hatching fluid
ingredient (Aquabeautine XL) in the first quarter of 2021.

For further information, please contact Espen Kvale, CEO, telephone +47 916 28
092

Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skin care products. ABT's cosmetics ingredients are
effective and they provide the cosmetics industry with natural alternatives to
traditional ingredients. ABT is also marketing and distributing natural skin
care products developed by partners towards consumers and professional users.
ABT's focus on commercialization and development of natural ingredients and
natural skin care products has been, and will continue to be, an important part
of the company's strategy going forward. Aqua Bio Technology is listed on
Euronext Expand.

CONTACTS

 * Espen Kvale, CEO, +47 916 28 092, espen.kvale@aquabiotech.no 

ATTACHMENTS

Download announcement as PDF.pdf -
https://kommunikasjon.ntb.no/ir-files/17847556/366/453/Download%20announcement%2
0as%20PDF.pdf

Click here for more information

© Oslo Bors ASA, source Oslo Stock Exchange